A353810 Stock Overview
Provides specialized piglet feed and feed additives solutions in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
EASY BIO,Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩3,615.00 |
52 Week High | ₩4,835.00 |
52 Week Low | ₩3,100.00 |
Beta | 0.95 |
11 Month Change | -3.34% |
3 Month Change | -15.73% |
1 Year Change | 13.86% |
33 Year Change | -22.76% |
5 Year Change | n/a |
Change since IPO | 256.75% |
Recent News & Updates
We Think EASY BIOInc (KOSDAQ:353810) Can Stay On Top Of Its Debt
Aug 07Statutory Profit Doesn't Reflect How Good EASY BIOInc's (KOSDAQ:353810) Earnings Are
Mar 28Shareholder Returns
A353810 | KR Food | KR Market | |
---|---|---|---|
7D | 2.8% | 2.9% | -1.0% |
1Y | 13.9% | 5.2% | 3.2% |
Return vs Industry: A353810 exceeded the KR Food industry which returned 5.2% over the past year.
Return vs Market: A353810 exceeded the KR Market which returned 3.2% over the past year.
Price Volatility
A353810 volatility | |
---|---|
A353810 Average Weekly Movement | 5.3% |
Food Industry Average Movement | 3.8% |
Market Average Movement | 5.5% |
10% most volatile stocks in KR Market | 11.6% |
10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A353810 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A353810's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | 127 | n/a | www.easybio.co.kr/en/main/ |
EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.
EASY BIO,Inc. Fundamentals Summary
A353810 fundamental statistics | |
---|---|
Market cap | ₩125.28b |
Earnings (TTM) | ₩17.34b |
Revenue (TTM) | ₩245.53b |
7.1x
P/E Ratio0.5x
P/S RatioIs A353810 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A353810 income statement (TTM) | |
---|---|
Revenue | ₩245.53b |
Cost of Revenue | ₩172.48b |
Gross Profit | ₩73.06b |
Other Expenses | ₩55.72b |
Earnings | ₩17.34b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 507.84 |
Gross Margin | 29.75% |
Net Profit Margin | 7.06% |
Debt/Equity Ratio | 293.4% |
How did A353810 perform over the long term?
See historical performance and comparison